DXCM vs. IDXX: DexCom vs. IDEXX Laboratories Stock Comparison
How do DexCom (DXCM) and IDEXX Laboratories (IDXX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
DexCom (DXCM) and IDEXX Laboratories (IDXX) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | DXCM | IDXX |
|---|---|---|
| Name | DexCom Inc. | IDEXX Laboratories, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 29.62 billion USD | 53.26 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | April 14, 2005 | June 21, 1991 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| Total Return (1Y) | 46.33% | -1.84% |
| Total Return (3Y, Annualized) | -4.50% | 18.42% |
| Total Return (5Y, Annualized) | -12.76% | 2.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| Volatility (1Y, Annualized) | 38.37% | 37.02% |
| Beta (5Y) | 1.43 | 1.44 |
| Max Drawdown (5Y) | -66.32% | -50.91% |
| Avg. Volume (3M) | 4.34M | 564.80K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| Sharpe Ratio (1Y) | 1.10 | -0.17 |
| Sortino Ratio (1Y) | 1.79 | -0.28 |
Profitability
ROE (TTM)
Both companies show strong equity returns, but IDEXX Laboratories (IDXX) at 68.93% is the standout with ROE above its industry range; DexCom (DXCM) at 37.67% also sits in the top quartile.
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
IDXX
Health Care Equipment & Services industry group
68.93%
- IDXX
- 68.93%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both DexCom (DXCM) at 19.42% and IDEXX Laboratories (IDXX) at 25.36% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
IDXX
Health Care Equipment & Services industry group
25.36%
- Max
- 29.35%
- IDXX
- 25.36%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both DexCom (DXCM) at 24.34% and IDEXX Laboratories (IDXX) at 33.14% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
IDXX
Health Care Equipment & Services industry group
33.14%
- Max
- 35.43%
- IDXX
- 33.14%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| ROE (TTM) | 37.67% | 68.93% |
| ROA (TTM) | 11.14% | 26.70% |
| Net Margin (TTM) | 19.42% | 25.36% |
| Operating Margin (TTM) | 24.34% | 33.14% |
| Gross Margin (TTM) | 63.42% | 62.72% |
Growth
Revenue Growth
Both DexCom (DXCM) at 15.60% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
DexCom (DXCM) at 47.18% sits in the top EPS growth quartile, while IDEXX Laboratories (IDXX) at 22.59% is closer to the peer norm — faster per-share earnings growth for DXCM.
Growth Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| Revenue Growth (YoY) | 15.60% | 10.42% |
| Revenue Growth (3Y CAGR) | 17.01% | 8.52% |
| EPS Growth (YoY) | 47.18% | 22.59% |
| EPS Growth (3Y CAGR) | 36.60% | 17.66% |
Financial Strength
Current Ratio (MRQ)
DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
IDXX
Health Care Equipment & Services industry group
1.19
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- IDXX
- 1.19
- Min
- 0.30
Debt / Equity (MRQ)
Both DexCom (DXCM) at 0.55 and IDEXX Laboratories (IDXX) at 0.52 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
IDXX
Health Care Equipment & Services industry group
0.52
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- IDXX
- 0.52
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| Current Ratio (MRQ) | 1.74 | 1.19 |
| Debt / Equity (MRQ) | 0.55 | 0.52 |
| Net Debt / EBITDA | -0.28 | 0.46 |
Dividends
Dividend Yield (TTM)
Neither DexCom (DXCM) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither DexCom (DXCM) nor IDEXX Laboratories (IDXX) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Both DexCom (DXCM) at 31.26 and IDEXX Laboratories (IDXX) at 45.56 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
IDXX
Health Care Equipment & Services industry group
45.56
- Max
- 80.41
- Q3
- 47.62
- IDXX
- 45.56
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both look expensive on sales: DexCom (DXCM) at 5.80 sits in the upper P/S ratio quartile, and IDEXX Laboratories (IDXX) at 11.42 prices even higher, above its industry range.
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
IDXX
Health Care Equipment & Services industry group
11.42
- IDXX
- 11.42
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Both look rich against book: DexCom (DXCM) at 11.68 sits in the upper P/B ratio quartile, and IDEXX Laboratories (IDXX) at 28.50 prices even higher, above its industry range.
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
IDXX
Health Care Equipment & Services industry group
28.50
- IDXX
- 28.50
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DXCM | IDXX |
|---|---|---|
| P/E Ratio (TTM) | 31.26 | 45.56 |
| P/S Ratio (TTM) | 5.80 | 11.42 |
| P/B Ratio (MRQ) | 11.68 | 28.50 |
| Free Cash Flow Yield (TTM) | 2.74% | 2.00% |